IBRITUMOMAB TIUXETAN
UNII 4Q52C550XK

Substance Identification & Data

This profile provides standardized clinical and technical data for Ibritumomab Tiuxetan, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4Q52C550XK.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 206181-63-7 and the RxNorm Concept ID (RxCUI) 262323. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4Q52C550XK

CAS Registry Number

206181-63-7

RxNorm Concept ID

262323

Detailed Substance Profile

Preferred Name

IBRITUMOMAB TIUXETAN

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

4Q52C550XK

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C29981

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

74890578

Unique identification number in the NCBI database of chemical substances.

INN ID

7873

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JJ-95

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Ibritumomab Tiuxetan. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.